KS

Krishna Sai Patha

Active Director Director DIN 06810922
DIN 06810922 First appointment Feb 2014 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Krishna Sai Patha

Data last updated:

Krishna Sai Patha is a Director at Tri'l Biotech Pharmaceuticals Private Limited (since 2014). The company operates in Chemicals.

DIN 06810922
Primary Designation Director
Industry Chemicals
First Appointment 01 Feb 2014
Oldest Company Age 22 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Feb 20142004Active

Board colleagues of Krishna Sai Patha

Directorship timeline

Open interactive timeline →
Tri'l Biotech Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Krishna Sai Patha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishna Sai Patha

Krishna Sai Patha currently holds 1 directorship: Tri'l Biotech Pharmaceuticals Private Limited (Director, since 01 Feb 2014).

Krishna Sai Patha was first appointed on 01 Feb 2014 as Director at Tri'l Biotech Pharmaceuticals Private Limited.

The current boards of Krishna Sai Patha's companies include Rajindar Kumar Patha (Tri'l Biotech Pharmaceuticals Private Limited), Vanaja Patha (Tri'l Biotech Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available